Tone-evening cosmetic peptide concept
Nonapeptide-1 Brightening Microneedle Patch OEM
A targeted radiance and tone-evening microneedle patch concept using Nonapeptide-1 as an ingredient direction for dark-spot appearance and localized brightening programs.






AI-generated product & process concepts. Final specifications are project-dependent.
Product architecture
Ingredient-led cosmetic microneedle patch concept
| Formula direction | Nonapeptide-1 with a cosmetic dissolving matrix; niacinamide, glutathione or hydration-support ingredients may be considered only after compatibility review. |
|---|---|
| Application formats | Targeted spot patches, cheek-zone patches and multi-patch radiance kits. |
| Development focus | Ingredient status by market, light and moisture stability, formula interactions, patch discoloration and finished-product claim testing. |
| Claim boundary | Describe the appearance of radiance, even tone or dark spots only when substantiated. Avoid disease, pigment-disorder or guaranteed skin-whitening claims. |
OEM and private-label options
Formula
Review peptide identity, supplier form, target content, matrix polymers and compatible supporting cosmetic ingredients.
Patch geometry
Choose forehead, smile-line, under-eye, spot or other application-area shapes with an appropriate array footprint.
Packaging
Develop moisture-protective sachets, trays, cartons, display boxes or premium kits for the intended channel.
What must be verified before scale-up
- Exact ingredient identity, purity, supplier carrier and target-market status.
- Compatibility with pH, water activity, polymers and the selected drying process.
- Needle-tip formation, mechanical integrity, dissolution and content uniformity.
- Finished-product stability in the final tray, sachet and secondary packaging.
- Consumer safety, instructions and substantiation for the final cosmetic claims.
See also: Brightening peptide microneedle patch platform.
Scope: This is an OEM development concept, not a finished-product efficacy promise. Formula, concentration, safety, claims and market status are confirmed for each project.
